Approval · Notice of Compliance 15778 · 2014
COMPONENT TE-G IMPLANTS: Notice of Compliance 15778
Issued July 8, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 15778
- Date
- July 8, 2014
- Company
- Elanco Division Eli Lilly Canada IncGuelph, Ontario, Canada
- Product type
- Veterinary
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Grrowth promotant
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| COMPONENT TE-G IMPLANTS | 02427486 | Dormant |
Medicinal ingredients
- ESTRADIOL 8 MG per DOSE
- TRENBOLONE ACETATE 40 MG per DOSE